Reginald Love Biography and Net Worth

Director of Strata Critical Medical

Reginald Love has served as one of our directors since September 2021. Mr. Love has served as a Senior Advisor at Apollo Global Management, a private global alternative investment management firm, since February 2020. Mr. Love previously served as Partner at RON Transatlantic EG, an international financial holding company with interests in the financial services, logistics, energy, industrial and beer sectors in the United States, Latin America and Europe, from 2012 to February 2020. Prior to joining RON Transatlantic EG, Mr. Love served at the White House as personal aide to President Barack Obama from 2009 to 2011, where he was responsible for assisting with the coordination and completion of the President’s daily schedule as well as coordinating with other White House offices to set up long and medium range planning. Mr. Love is a graduate of Duke University and has an M.B.A. from the Wharton School at the University of Pennsylvania. Mr. Love also serves on the boards of Cox Media Group, a private American media conglomerate, and the National Summer Learning Association, an American non-profit organization focused on education.

What is Reginald Love's net worth?: The estimated net worth of Reginald Love is at least $900.86 thousand as of August 10th, 2026. Mr. Love owns 146,481 shares of Strata Critical Medical stock worth more than $900,858 as of August 21st. This net worth estimate does not reflect any other assets that Mr. Love may own. Learn More about Reginald Love's net worth.
How do I contact Reginald Love?: The corporate mailing address for Mr. Love and other Strata Critical Medical executives is 55 HUDSON YARDS, 14TH FLOOR, NEW YORK, NY, 10001. Strata Critical Medical can also be reached via phone at (212) 967-1009 and via email at [email protected]. Learn More on Reginald Love's contact information.
Has Reginald Love been buying or selling shares of Strata Critical Medical?: During the last quarter, Reginald Love has sold $29,273.25 in Strata Critical Medical stock. Most recently, Reginald Love sold 5,091 shares of the business's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $5.75, for a transaction totalling $29,273.25. Following the completion of the sale, the director now directly owns 146,481 shares of the company's stock, valued at $842,265.75. Learn More on Reginald Love's trading history.
Who are Strata Critical Medical's active insiders?: Strata Critical Medical's insider roster includes Amir Cohen (CAO), William Heyburn (CEO), Reginald Love (Director), and Melissa Tomkiel (CEO). Learn More on Strata Critical Medical's active insiders.
Are insiders buying or selling shares of Strata Critical Medical?: In the last twelve months, insiders at the sold shares 6 times. They sold a total of 122,022 shares worth more than $716,457.22. The most recent insider tranaction occured on August, 10th when Director Reginald Love sold 5,091 shares worth more than $29,273.25. Insiders at Strata Critical Medical own 15.5% of the company. Learn More about insider trades at Strata Critical Medical.
Information on this page was last updated on 8/10/2026.

Reginald Love Insider Trading History at Strata Critical Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/10/2026	Sell	5,091	$5.75	$29,273.25	146,481

Reginald Love Buying and Selling Activity at Strata Critical Medical

Strata Critical Medical Company Overview

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Today's Range

Now: $6.19

$6.00

$6.29

50 Day Range

MA: $5.46

$4.87

$6.03

2 Week Range

Now: $6.19

$3.85

$6.50

Volume

677,543 shs

Average Volume

976,478 shs

Market Capitalization

$547.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.25